Human T-cell leukemia virus type 1 can infect a wide variety of cells in mice
Open accessAbstract
Analysis of human T‐cell leukemia virus type 1 (HTLV‐1)‐infected cell types and the interplay of these infected cells in vivo should provide valuable information to elucidate the pathogenesis of HTLV‐1‐associated diseases in humans and in animal models. In this study, HTLV‐1‐infected cell types were identified in HTLV‐1‐infected C3H/HeJ mice. Pan T, CD+4, CD8+8, granulocyte and pan B cell fractions in the splenocytes of MT‐2 cell‐inoculated mice were sorted by use of their cell surface high‐density expression of CD 3e, CD 4, CD 8, Gr‐1 and B 220 antigens, respectively, with a fluorescence‐activated cell sorter. the pX sequence of HTLV‐1 provirus in the lysate of each fraction was amplified by polymerase chain reaction and detected by Southern hybridization. Interestingly, in addition to the CD+4 cell fraction, the pX sequence was also found in CD8+ cell, B cell and granulocyte fractions. The broad cell spectrum of HTLV‐1 infection in mice is consistent with the situation in humans. Our findings indicate that HTLV‐1 receptor or coreceptor is widely distributed among different cell types in mice.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Immunocompetent HTLV-1 carrier mouse models demonstrate very little in vivo spread of infection with no evidence of disease, except for one report of tumorigenesis.
“A caveat, however, is that immunocompetent HTLV-1 carrier mouse models demonstrate very little in vivo spread of infection with no evidence of disease, except for one report of tumorigenesis [125,126].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [125]
The Abstract and Materials and Methods describe an HTLV-1-infected C3H/HeJ mouse model, supporting the citation as an example of a carrier mouse model. The Abstract and Discussion document infection in multiple cell types, but do not establish that in vivo spread was very limited or report an absence of disease or an exception involving tumorigenesis. No page numbers are available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Gessain, A., Vernant, J. C., Maurs, L., Barin, F., Gout, O., Calender, A., & de Thé, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92734-5 · Cited by 2,812 · see citing works
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,381 · see citing works
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252 · see citing works
Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402 · see citing works
Wei, P., Garber, M. E., Fang, S.-M., Fischer, W. H., & Jones, K. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80939-3 · Cited by 1,251 · see citing works
CHRONIC INFLAMMATORY ARTHROPATHY ASSOCIATED WITH HTLV-I
Nishioka, K., Maruyama, I., Sato, K., Kitajima, I., Nakajima, Y., & Osame, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90038-x · Cited by 480 · see citing works
Infective dermatitis of Jamaican children: a marker for HTLV-I infection
Blattner, W., LaGrenade, L., Hanchard, B., Fletcher, V., & Cranston, B. (1990) · The Lancet · doi:10.1016/0140-6736(90)92896-p · Cited by 453 · see citing works
Kinoshita, T., Shimoyama, M., Tobinai, K., Ito, M., Ito, S., Ikeda, S., Tajima, K., Shimotohno, K., & Sügimura, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5620 · Cited by 282 · see citing works
In Vivo Infection of Human T-Cell Leukemia Virus Type I in Non-T Cells
Koyanagi, Y., Itoyama, Y., Nakamura, N., Takamatsu, K., Kira, J., Iwamasa, T., Goto, I., & Yamamoto, N. (1993) · Virology · doi:10.1006/viro.1993.1451 · Cited by 229 · see citing works
Multi‐step Carcinogenesis Model for Adult T‐cell Leukemia
Okarmoto, T., Ohno, Y., Tsugane, S., Watanabe, S., Shimoyama, M., Tajima, K., Miwa, M., & Shimotohno, K. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb02289.x · Cited by 198 · see citing works
Self-citationYamaguchi, K., Seiki, M., Yoshida, M., Nishimura, H., Kawano, F., & Takatsuki, K. (1984) · Blood · doi:10.1182/blood.v63.5.1235.1235 · Cited by 155 · see citing works
Infection of human endothelial cells by human T-cell leukemia virus type I.
Hoxie, J. A., Matthews, D. M., & Cines, D. B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7591 · Cited by 142 · see citing works
Hoshino, H., Esumi, H., Miwa, M., Shimoyama, M., Minato, K., Tobinai, K., Hirose, M., Watanabe, S., Inada, N., Kinoshita, K.-I., et al. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6061 · Cited by 142 · see citing works
Self-citationHuman T Cell Leukemia Viruses Use a Receptor Determined by Human Chromosome 17
Sommerfelt, M. A., Williams, B. P., Clapham, P. R., Solomon, E., Goodfellow, P. N., & Weiss, R. A. (1988) · Science · doi:10.1126/science.3201246 · Cited by 141 · see citing works
Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection
Browning, J., Horner, J. W., Pettoello‐Mantovani, M., Raker, C., Yurasov, S., DePinho, R. A., & Goldstein, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14637 · Cited by 131 · see citing works
Kobayashi, N., Konishi, H., Sabe, H., Shigesada, K., Noma, T., Honjo, T., & Hatanaka, M. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01974.x · Cited by 93 · see citing works
Furukawa, Y., Osame, M., Kubota, R., Tara, M., & Yoshida, M. (1995) · Blood · doi:10.1182/blood.v85.7.1865.bloodjournal8571865 · Cited by 91 · see citing works
Leon‐Monzon, M., Illa, I., & Dalakas, M. C. (1994) · Annals of Neurology · doi:10.1002/ana.410360414 · Cited by 75 · see citing works
The Long Terminal Repeat Sequences of a Novel Human Endogenous Retrovirus
O’Connell, C. D., & Cohen, M. (1984) · Science · doi:10.1126/science.6505687 · Cited by 71 · see citing works
Yoshikura, H., Nishida, J., Yoshida, M., et al. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330606 · Cited by 61 · see citing works
Feuer, G., Fraser, J. K., Zack, J. A., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.4038-4044.1996 · Cited by 61 · see citing works
Infection of rats with HTLV‐1: A small‐animal model for HTLV‐1 carriers
Suga, T., KAMEYAMA, T., Kinoshita, T., Shimotohno, K., Matsumura, M., Tanaka, H., Kushida, S., Ami, Y., Uchida, M., Uchida, K., et al. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490522 · Cited by 52 · see citing works
Self-citationHuman and Simian Glial Cells Infected by Human T-Lymphotropic Virus Type I in Culture
Watabe, K., Saida, T., & Kim, S. U. (1989) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198911000-00003 · Cited by 48 · see citing works
SEROLOGICAL SURVEY OF THE IRIOMOTE CAT (FELIS IRIOMOTENSIS) IN JAPAN
Mochizuki, M., AKUZAWA, M., & NAGATOMO, H. (1990) · Journal of Wildlife Diseases · doi:10.7589/0090-3558-26.2.236 · Cited by 45 · see citing works
Transmission of Human T-Cell Leukemia Virus Type 1 to Mice
Fang, J., Kushida, S., Feng, R., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3952-3957.1998 · Cited by 35 · see citing works
Self-citationKushida, S., Mizusawa, H., Matsumura, M., Tanaka, H., Ami, Y., Hori, M., YAGAMI, K.-I., KAMEYAMA, T., Tanaka, Y., & Yoshida, A. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7221-7226.1994 · Cited by 29 · see citing works
Franchini, G., Mann, D. L., Popovič, M., et al. (1985) · Leukemia Research · doi:10.1016/0145-2126(85)90116-x · Cited by 26 · see citing works
LENO, M., Simpson, R. J., Bowers, F. S., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1575 · Cited by 23 · see citing works
Hiramatsu, K., Masuda, M., & Yoshikura, H. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910370420 · Cited by 19 · see citing works
Expression of Myeloid Cell Phenotypes by a Novel Adult T-Cell Leukemia/Lymphoma Cell Line
Koziumi, S., Iwanaga, M., Imai, S., et al. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.9.690 · Cited by 12 · see citing works
Integration of HTLV-1 Provirus into Mouse Transforming Growth Factor-α Gene
Fang, J., Kushida, S., Feng, R., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6557 · Cited by 10 · see citing works
Self-citationRequirement for HIV-1 TAR sequences for Tat activation in rodent cells
Sutton, J. A., Braddock, M., Kingsman, A. J., et al. (1995) · Virology · doi:10.1016/s0042-6822(95)80090-5 · Cited by 6 · see citing works
Killer cell systems of cynomolgus monkeys experimentally infected with HTLV-1.
Yoshimura, N., Nakamura, H. K., HONJO, S., et al. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.6.1970 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Current State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22 · see citing works
“…mice leads to oncogenesis and other less typical manifestations of HTLV-1 infection; however, leukaemia/lymphoma induction is rare and does not fully capture the disease environment, but it has been useful to elucidate the role that tax plays in the disruption of T cell function and establish…”
Background
- Authors
- Feng, R., Tanaka, M., Abe, H., Arashi, N., Sun, B., Uchida, K., & Miwa, M.
- Affiliations
- University of Tsukuba (JP)
- Corresponding author
- Miwa, Masanao
- Venue
- Japanese Journal of Cancer Research
- Publisher
- Wiley
- Published
- 1999-01
- Volume
- 90
- Issue
- 1
- Pages
- 48-54
- ISSN
- 0910-5050 (ISSN-L)
- PMC
- PMC5925986
- OpenAlex
- W2021141892
- Cited by
- 11
- References
- 33
- Citations by year
- 2024: 1 · 2014: 1 · 2013: 1
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Japanese Journal of Cancer Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HTLV-1, HTLV-1 infection, C3H/HeJ mice, MT-2 cells, CD4+ T cells, CD8+ T cells, B cells, granulocytes, co-receptors, splenocytes
- MeSH terms
- Animals, Antigens, Differentiation, B-Lymphocytes, Cell Line, Flow Cytometry, Granulocytes, Humans, Mice, Inbred C3H, Receptors, Virus, Spleen, T-Lymphocytes, Human T-lymphotropic virus 1, HTLV-I Infections, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review